Carregant...
Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases
Adrenomedullin (ADM) 2/intermedin (IMD) is a short peptide that belongs to the CGRP superfamily. Although it shares receptors with CGRP, ADM and amylin, ADM2 has significant and unique functions in the cardiovascular system. In the past decade, the cardiovascular effect of ADM2 has been carefully an...
Guardat en:
| Publicat a: | Br J Pharmacol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5867024/ https://ncbi.nlm.nih.gov/pubmed/28407200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13814 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|